All Stories

  1. Studying Bordetella pertussis Populations by Use of SNPeX, a Simple High-Throughput Single Nucleotide Polymorphism Typing Method
  2. Complete Genome Sequences of Bordetella pertussis Isolates B1917 and B1920, Representing Two Predominant Global Lineages
  3. Proteomics-Identified Bvg-Activated Autotransporters Protect against Bordetella pertussis in a Mouse Model
  4. Estimation of the serial interval of pertussis in Dutch households
  5. Genes for the Filamentous Hemagglutinin and Fimbriae of Bordetella pertussis: Colocation, Coregulation, and Cooperation?
  6. Correction: Differentially Expressed Genes in Bordetella pertussis Strains Belonging to a Lineage Which Recently Spread Globally
  7. Differentially Expressed Genes in Bordetella pertussis Strains Belonging to a Lineage Which Recently Spread Globally
  8. The vaccine potential of Bordetella pertussis biofilm-derived membrane proteins
  9. Cost-effectiveness of targeted vaccination to protect new-borns against pertussis: Comparing neonatal, maternal, and cocooning vaccination strategies
  10. Pertussis in the Netherlands, is the current vaccination strategy sufficient to reduce disease burden in young infants?
  11. Pertussis resurgence: waning immunity and pathogen adaptation – two sides of the same coin
  12. Estimation of Household Transmission Rates of Pertussis and the Effect of Cocooning Vaccination Strategies on Infant Pertussis
  13. Small Mutations in Bordetella pertussis Are Associated with Selective Sweeps
  14. Temporal Trends in Bordetella pertussis Populations, Denmark, 1949–2010
  15. Characterization of Bordetella holmesii isolates from patients with pertussis-like illness in the Netherlands
  16. Molecular typing of Bordetella parapertussis isolates circulating in Pakistan
  17. Pertussis in infancy and the association with respiratory and cognitive disorders at toddler age
  18. SNP-Based Typing: A Useful Tool to Study Bordetella pertussis Populations
  19. Whooping cough in Pakistan: Bordetella pertussis vs Bordetella parapertussis in 2005–2009
  20. Pertussis: a matter of immune modulation
  21. Appearance of Fim3 and ptxP3-Bordetella pertussis strains, in two regions of Sweden with different vaccination programs
  22. Studies on Prn Variation in the Mouse Model and Comparison with Epidemiological Data
  23. Seroprevalence of Pertussis in the Netherlands: Evidence for Increased Circulation of Bordetella pertussis
  24. Comparative genomics of prevaccination and modern Bordetella pertussis strains
  25. Bordetella pertussis Clones Identified by Multilocus Variable-Number Tandem-Repeat Analysis
  26. Bordetella pertussis and vaccination: The persistence of a genetically monomorphic pathogen
  27. Correction: Comparative genomic profiling of Dutch clinical Bordetella pertussis isolates using DNA microarrays: identification of genes absent from epidemic strains
  28. Correction: Molecular Evolution of the Two-Component System BvgAS Involved in Virulence Regulation in Bordetella
  29. Molecular Evolution of the Two-Component System BvgAS Involved in Virulence Regulation in Bordetella
  30. Bordetella pertussis Strains with Increased Toxin Production Associated with Pertussis Resurgence
  31. Improving pertussis vaccination
  32. An investigation into the cause of the 1983 whooping cough epidemic in the Netherlands
  33. Economic analysis of pertussis illness in the Dutch population: Implications for current and future vaccination strategies
  34. The role of Toll-like receptor-4 in pertussis vaccine-induced immunity
  35. Maternal vaccination against pertussis – Authors' reply
  36. Impact of Acellular Pertussis Preschool Booster Vaccination on Disease Burden of Pertussis in The Netherlands
  37. Antibody responses to defined regions of theBordetella pertussisvirulence factor pertactin
  38. Comparative genomic profiling of Dutch clinical Bordetella pertussis isolates using DNA microarrays: Identification of genes absent from epidemic strains
  39. Comparative gene expression profiling in two congenic mouse strains following Bordetella pertussis infection
  40. Characterization of Bordetella pertussis clinical isolates that do not express the tracheal colonization factor
  41. Comparative Genomics of Bordetella pertussis Reveals Progressive Gene Loss in Finnish Strains
  42. The case for maternal vaccination against pertussis
  43. A novel strategy to mimic discontinuous protective epitopes using a synthetic scaffold
  44. The role of peptide loops of the Bordetella pertussis protein P.69 pertactin in antibody recognition
  45. Lung response to Bordetella pertussis infection in mice identified by gene-expression profiling
  46. Lung pathology and immediate hypersensitivity in a mouse model after vaccination with pertussis vaccines and challenge with Bordetella pertussis
  47. Preclinical and Clinical Safety Studies on DNA Vaccines
  48. Bordetella pertussis, the Causative Agent of Whooping Cough, Evolved from a Distinct, Human-Associated Lineage of B. bronchiseptica
  49. Pulsed-field gel electrophoresis analysis of Bordetella pertussis populations in various European countries with different vaccine policies
  50. The Bordetella pertussis virulence factor P.69 pertactin retains its immunological properties after overproduction in Escherichia coli
  51. Bordetella pertussis Isolates, Finland
  52. Efficacies of whole cell and acellular pertussis vaccines against Bordetella parapertussis in a mouse model
  53. Reply
  54. Crucial Role of Antibodies to Pertactin in Bordetella pertussis Immunity
  55. Association of Bordetella pertussis with host immune cells in the mouse lung
  56. Bordetella pertussis Protein Pertactin Induces Type‐Specific Antibodies: One Possible Explanation for the Emergence of Antigenic Variants?
  57. Adaptation of Bordetella pertussis to Vaccination: A Cause for Its Reemergence?
  58. Targeting to Fcγ Receptors, But Not CR3 (CD11b/CD18), Increases Clearance of Bordetella pertussis
  59. Polymorphism in Bordetella pertussis Pertactin and Pertussis Toxin Virulence Factors in the United States, 1935–1999
  60. Genesis of BRO β‐lactamase‐producing Moraxella catarrhalis: evidence for transformation‐mediated horizontal transfer
  61. Analysis of Moraxella catarrhalis by DNA Typing: Evidence for a Distinct Subpopulation Associated with Virulence Traits
  62. Evidence for an intracellular niche for Bordetella pertussis in broncho-alveolar lavage cells of mice
  63. Temporal Trends in the Population Structure of Bordetella pertussis during 1949–1996 in a Highly Vaccinated Population
  64. The psychrotrophic bacterium Yersinia enterocolitica requires expression of pnp, the gene for polynucleotide phosphorylase, for growth at low temperature (5°C)
  65. PCR based diagnosis of Pertussis; Development of the technique and its clinical validation
  66. The evolution of epidemic Vibrio cholerae strains
  67. Induction of feline immunodeficiency virus specific antibodies in cats with an attenuated Salmonella strain expressing the Gag protein
  68. Induction of an antibody response in mice against human papillomavirus (HPV) type 16 after immunization with HPV recombinant Salmonella strains
  69. Genetic organization and functional analysis of the otn DNA essential for cell‐wall polysaccharide synthesis in Vibrio cholerae O139
  70. From whole cell to acellular pertussis vaccines
  71. Construction and evaluation of an expression vector allowing the stable expression of foreign antigens in a Salmonella typhimurium vaccine strain
  72. Mutational analysis of the Bordetella pertussis fim/fha gene cluster: identification of a gene with sequence similarities to haemolysin accessory genes involved in export of FHA
  73. Isolation of a putative fimbrial adhesin from Bordetella pertussis and the identification of its gene
  74. Phase variation of H. influenzae fimbriae: Transcriptional control of two divergent genes through a variable combined promoter region
  75. Isolation of a Repeated Sequence from the Genome of Bordetella parapertussis with Characteristics of an Insertion Sequence Element
  76. Organization and Function of Genes Involved in Biogenesis of FHA and Fimbriae
  77. Regulation of the Genes Involved in the Biogenesis of FHA and Fimbriae
  78. Isolation and Characterization of Fim D, a Fimbrial Associated Protein of Bordetella pertussis
  79. A Novel Gene Involved in FHA Biogenesis
  80. Characterization of a Bordetella pertussis fimbrial gene cluster which is located directly downstream of the filamentous haemagglutinin gene
  81. Construction and analysis of Bordetella pertussis mutants defective in the production of fimbriae
  82. The Analysis of Bordetella Pertussis Fimbrial Mutants in a Rabbit Model
  83. Expression of foreign epitopes in P-fimbriae ofEscherichia coli
  84. Structure of the Bordetella pertussis gene coding for the serotype 3 fimbrial subunit
  85. Virulence factors of Bordetella pertussis
  86. Characterization of fimbrial subunits from Bordetella species
  87. Excretion of proteins by gram-negative bacteria: export of bacteriocins and fimbrial proteins byEscherichia coli
  88. The Use of Minicells and Maxicells to Detect the Expression of Cloned Genes
  89. The Use of Restriction Endonucleases and T4 DNA Ligase
  90. Subcellular localization of polypeptides involved in the biosynthesis of K88ab fimbriae
  91. The nucleotide sequence of the gene encoding the K88ab protein subunit of procine enterotoxigenic Escherichia coli